Blumhouse and Atomic Monster Drop 'Monster' for New Blumhouse Atomic Identity

Key points

• The combined entity is now called Blumhouse Atomic, replacing the previous name Blumhouse Atomic Monster.
• Blumhouse and Atomic Monster will remain separate labels under the new corporate umbrella, each with their own development teams.
• Since the 2024 merger, the company has earned over $2.5 billion in global box office against less than $330 million in production costs.
• Recent hits include 'Obsession' ($525 million global) and 'Backrooms' ($400.6 million global), both of which became the highest-grossing films for their respective distributors.
• The company has expanded into television, gaming, and live experiences, including a Broadway adaptation of 'Paranormal Activity' and the game 'Grave Seasons.'
• Sam Zimmerman was appointed SVP of Development and Acquisitions to oversee genre films with budgets under $5 million.

Background

This rebranding follows the 2024 merger of Blumhouse and Atomic Monster, which was initially announced as Blumhouse Atomic Monster. In October 2026, the company revealed its 2027 slate at New York Comic Con, including 'The Exorcist: Martyrs' and a new 'Paranormal Activity' film. In September 2026, Mike P. Nelson was hired to direct the next 'Saw' installment, produced by James Wan and Jason Blum, marking the first time the original creators have been directly involved since 2006. The company has also been expanding into new media, including partnerships with internet creators and adaptations of video games like 'Amanda the Adventurer.'

How outlets are covering it

The Hollywood Reporter emphasizes the financial success of the merger, citing $2.5 billion in box office revenue against $330 million in budgets, and highlights the expansion into television and games. Deadline focuses on the strategic hiring of Sam Zimmerman and the first-look deal with Divide/Conquer to develop cost-efficient genre films. A.V. Club notes the cleaner branding of dropping 'Monster' and highlights the success of 'Obsession' and 'Backrooms' as the highest-grossing films for Focus Features and A24, respectively. TheWrap provides a comprehensive overview of the 2027 slate and the company's expansion into live entertainment and consumer products. All sources agree on the financial success and the continued operation of Blumhouse and Atomic Monster as separate labels, but differ in emphasis on specific strategic moves and future projects.

Why it matters

The rebranding signals a new phase for Blumhouse Atomic, emphasizing its growth and diversification beyond traditional film production. The company's success in generating high returns on low budgets has set a new standard for the horror industry, influencing other studios to invest in emerging filmmakers and cost-efficient productions. The expansion into television, gaming, and live experiences reflects a broader trend in the entertainment industry to leverage intellectual property across multiple platforms. This move also highlights the importance of brand identity in the competitive horror market, where distinct labels can attract different audiences and creative talent.

What to watch

The company is expected to continue expanding its slate of original films and established franchises, with a focus on high-concept, cost-efficient genre films. The appointment of Sam Zimmerman and the first-look deal with Divide/Conquer suggest a continued emphasis on discovering new voices and developing projects with budgets under $5 million. The 2027 slate, including 'The Exorcist: Martyrs' and 'Paranormal Activity,' will be key to measuring the success of the new branding and strategic direction. The company's expansion into television, gaming, and live experiences will also be closely watched as it seeks to diversify its revenue streams and reach new audiences.